Drug intelligence / Profile preview

dutasteride + tamsulosin hydrochloride

Development stage
Approved
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

**Dutasteride + tamsulosin hydrochloride** is a fixed-dose combination medication used in the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. The combination consists of two pharmacologically distinct drugs: **dutasteride**, a dual 5-alpha-reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), thereby decreasing prostate size; and **tamsulosin hydrochloride**, a selective alpha-1 adrenergic receptor antagonist that relaxes the smooth muscle in the prostate and bladder neck to improve urinary flow. This combination provides more effective relief of BPH symptoms and reduces disease progression compared with monotherapy. It is taken orally, typically as a single daily capsule, and studied under the brand name Jalyn, among others.

Brand names
JalynDutasteride/Tamsulosin Hydrochloride
Other names
dutasteride and tamsulosindutasteride/tamsulosin
02

Targets

ADRA1A (α1A)SRD5A1 (Steroid 5-alpha-reductase type 1)SRD5A2 (Steroid 5-alpha-reductase type II)

Beyond the preview

Go deeper on dutasteride + tamsulosin hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dutasteride + tamsulosin hydrochloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call